A few day ago, Schering-Plough ceo Fred Hassan appeared on CNBC's Mad Money, where he spoke with Jim Cramer, the hyperactive host, about the controversy surrounding Vytorin. In particular, Cramer asked questions about the famous Enhance trial, which found the cholesterol pill wasn't any better at reducing arterial plague in the carotid artery compared with Zocor, and even found a statistically insignificant buildup.
Pharmalot » Hassan Comes Clean About Vytorin. Or Did He?
Posted by G00gle 929 days ago (http://www.pharmalot.com)Who Voted for this Story
Comments